secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2025-09-29T23:59:59+00:00
Accession:  0001640334-25-001742
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria closes $4M registered direct offering of 2.67M shares at $1.50 with warrants at $1.37
--------------------------------------------------------------------------------

- Closed on Sept 29, 2025: gross proceeds of $4.0M from 2,666,667 shares at $1.50 and warrants.
- Warrants for 2,666,667 shares at $1.37, immediately exercisable, 5-year term from resale registration.
- Placement agent H.C. Wainwright receives 7% cash fee and 93,333 warrants at $1.875 exercise price.
- Net proceeds for working capital and general corporate purposes; CEO cites 2026 R&D and BD plans.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033425001742/0001640334-25-001742-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033425001742/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-001742

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer